Who is hiring? Abandon sinking ship!

Quote






anonymous said:
I agree with your logical thinking here, but don't believe 217 will be out that soon. So the decision will be to decide if you want to stay for a year or more of this pure hell. There are much better companies out there that don't babysit and treat their employees with dignity and respect. The culture is toxic and its becoming intolerable to work here, especially with the overly aggressive and out-of-line compliance department. They are insanely rigid, overly micromanage, and consistently breed distrust. Where is the great culture they promised and never delivered? They don't have a clue to what they are doing here. You can't even get business cards in this place. For a company to worry so much about a new company logo versus more important things is shocking. Yet they continue to hire and promote, which is very disturbing. You can keep your t-shirt and btw, that straw? Prone to bacteria and mold. Enough said.
Click to expand...

you put thought into this post

Sounds like a bad environment

maybe even a bad investment
 


































































Discovery is a risky business however this share price was seriously out of whack. The low sales numbers of ZULRESSO coupled with the bad news on the follow up indication means a race to the bottom. Physicians are not seeing the value and REMS makes it even less attractive. Teens within weeks. The viability of the company as an independent entity is questionable. Cash burn rate needs addressed. A lot of sales and marketing and patient support services overhead.
 






Discovery is a risky business however this share price was seriously out of whack. The low sales numbers of ZULRESSO coupled with the bad news on the follow up indication means a race to the bottom. Physicians are not seeing the value and REMS makes it even less attractive. Teens within weeks. The viability of the company as an independent entity is questionable. Cash burn rate needs addressed. A lot of sales and marketing and patient support services overhead.
 












Thank you for your expert analysis and advice. I’m sure glad we have TBSs like you selling this complex product! I’m sure you are a great resource to your customers!

anonymous said:
Discovery is a risky business however this share price was seriously out of whack. The low sales numbers of ZULRESSO coupled with the bad news on the follow up indication means a race to the bottom. Physicians are not seeing the value and REMS makes it even less attractive. Teens within weeks. The viability of the company as an independent entity is questionable. Cash burn rate needs addressed. A lot of sales and marketing and patient support services overhead.
Click to expand...
 






























Top Bottom
Back
Quote